Le Lézard
Classified in: Health
Subjects: AWD, NPT, DIS

"The Arc Tank" Competition Grants $200K to Winning Proposals


BOSTON, Nov. 16, 2017 /PRNewswire/ --  Northeast Arc announced the winners of the final round of "The Arc Tank" competition that was created to positively disrupt the conventional methods of providing services to persons with disabilities. The winners are:  YMCA of the North Shore, Pathways to Inclusive Health Care and Disrupting the Guardianship Pipeline.  They were selected by a panel of judges who heard their pitches at an event held yesterday at the John F. Kennedy Presidential Library, a partner in the initiative.  The winning proposals received awards from the Changing Lives Fund that was established through a $1 million donation from Steven P. Rosenthal, founder of West Shore, LLC.

Y's Water Wise ? Submitted by the YMCA of the North Shore, Beverly, Mass., to develop "Water Wise", a water safety program for children with ASD.  According to a 2017 study, children with autism are 160 times as likely to die from drowning as other children.  Children with ASD often feel anxious, and wandering, especially toward water, is one way they seek relief. Awarded $30,000.

Pathways to Inclusive Health Care ? Submitted by Dr. Carol Langer, Associate Professor at UMass Medical Center and an instructor at the Harvard School of Public Health, to develop a pipeline of healthcare professionals equipped to provide quality healthcare to people with intellectual disabilities and autism.  The project would focus on the precipitous transition from pediatrics to adult medicine care for this population. Awarded $80,000.

Disrupting the Guardianship Pipeline ? Submitted by the Center for Public Representation of Northampton, Mass., to create a "Massachusetts Supported Decision-Making Incubator: to provide an effective alternative to guardianship which is often the only option for people with intellectual disabilities and developmental disabilities. Awarded $85,000

More than 100 proposals were submitted from across the globe and throughout the U.S. by an array of inventors, engineers, human service providers, parents, college students, and persons with disabilities. Northeast Arc is a human services organization that annually serves 9,000 children and adults from 190 Massachusetts cities and towns who have a broad range of disabilities including intellectual disabilities and autism. 

"The Ark Tank will continue full steam ahead as we monitor the progress of our winning projects and hope that they achieve success so the lives of persons with disabilities can improve through their innovative ideas," said  Jo Ann Simons, CEO of Northeast Arc. "With Steven Rosenthal's vision and philanthropy, we hope to shake up the way that services are provided and lay the groundwork for even more ideas to come forward in the future."  Simons said Northeast Arc will host another Arc Tank Competition in 2018 and will announce details soon.

Judges:

Judges received support from David Chang, an entrepreneur and active angel investor and from Rick Rader, MD, Vice President, American Academy of Developmental Medicine and Dentistry. MC for the event was T.J. Winick, former correspondent for ABC News, and Northeast Arc board member.

SOURCE Northeast Arc


These press releases may also interest you

at 21:59
Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high quality medicines for the treatment of oncology, cardiovascular and metabolic, autoimmune, ophthalmology...

at 21:27
Labcorp , a global leader of innovative and comprehensive laboratory services, announced today that it has been selected as the winning bidder for select assets of Invitae, a leading medical genetics company.  Before the transaction can proceed,...

at 21:19
Invitae , a leading medical genetics company, announced that Labcorp , a global leader of innovative and comprehensive laboratory services, has been selected...

at 21:05
Valcare Medical, Inc., a leading innovator in transcatheter-based mitral...

at 21:02
Ascentage Pharma (6855.HK), a global biopharmaceutical company engaged in developing novel therapies for cancer, chronic hepatitis B (CHB), and age-related diseases, announced today that results from four clinical studies of the company's three key...

at 19:59
Genomma Lab Internacional, S.A.B. de C.V. (BMV: LAB B) ("Genomma" or "the Company"), today announced its results for the first quarter of 2024. All figures included herein are stated in nominal Mexican pesos and have been prepared in accordance with...



News published on and distributed by: